Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE4.2600
- TODAY'S CHANGE (%)0.1700 (4.1565%)
- Bid / Lots4.1600/ 58
- Ask / Lots4.2600/ 35
- Open / Previous Close4.0800 / 4.0900
- Day Range
- 52 Week Range
- Volume331,704
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 5517 | 4.0713 |
| 09:33 ET | 3430 | 4.095 |
| 09:35 ET | 900 | 4.1 |
| 09:37 ET | 100 | 4.12 |
| 09:42 ET | 2101 | 4.105 |
| 09:44 ET | 1170 | 4.07 |
| 09:46 ET | 500 | 4.085 |
| 09:50 ET | 338 | 4.100155 |
| 09:51 ET | 4200 | 4.11 |
| 09:53 ET | 200 | 4.12 |
| 09:55 ET | 250 | 4.13 |
| 09:57 ET | 100 | 4.14 |
| 10:00 ET | 217 | 4.125 |
| 10:02 ET | 5300 | 4.1 |
| 10:04 ET | 100 | 4.09 |
| 10:06 ET | 2100 | 4.085 |
| 10:08 ET | 200 | 4.07 |
| 10:09 ET | 459 | 4.05 |
| 10:13 ET | 1700 | 4.07 |
| 10:15 ET | 1244 | 4.065 |
| 10:18 ET | 200 | 4.055 |
| 10:20 ET | 1550 | 4.05 |
| 10:22 ET | 1000 | 4.0599 |
| 10:24 ET | 500 | 4.0677 |
| 10:26 ET | 1600 | 4.0635 |
| 10:27 ET | 100 | 4.065 |
| 10:29 ET | 4515 | 4.0797 |
| 10:31 ET | 1622 | 4.08 |
| 10:33 ET | 100 | 4.08 |
| 10:36 ET | 400 | 4.095 |
| 10:38 ET | 200 | 4.1 |
| 10:40 ET | 700 | 4.095 |
| 10:42 ET | 900 | 4.1 |
| 10:44 ET | 6237 | 4.125 |
| 10:45 ET | 1200 | 4.125 |
| 10:47 ET | 6801 | 4.16 |
| 10:49 ET | 642 | 4.155 |
| 10:51 ET | 11921 | 4.17 |
| 10:54 ET | 900 | 4.165 |
| 10:56 ET | 4343 | 4.145 |
| 10:58 ET | 100 | 4.145 |
| 11:00 ET | 6105 | 4.165 |
| 11:02 ET | 1900 | 4.155 |
| 11:03 ET | 1800 | 4.1379 |
| 11:05 ET | 1836 | 4.1392 |
| 11:07 ET | 3200 | 4.1199 |
| 11:09 ET | 600 | 4.115 |
| 11:12 ET | 278 | 4.115 |
| 11:14 ET | 850 | 4.12 |
| 11:16 ET | 600 | 4.125 |
| 11:18 ET | 2300 | 4.1397 |
| 11:20 ET | 1600 | 4.15 |
| 11:21 ET | 1951 | 4.16 |
| 11:23 ET | 100 | 4.16 |
| 11:25 ET | 100 | 4.17 |
| 11:30 ET | 1100 | 4.18 |
| 11:34 ET | 599 | 4.17 |
| 11:36 ET | 2100 | 4.18 |
| 11:38 ET | 3359 | 4.185 |
| 11:39 ET | 500 | 4.1854 |
| 11:41 ET | 200 | 4.19 |
| 11:43 ET | 100 | 4.19 |
| 11:45 ET | 100 | 4.19 |
| 11:48 ET | 8894 | 4.19 |
| 11:50 ET | 3853 | 4.195 |
| 11:54 ET | 200 | 4.195 |
| 11:56 ET | 449 | 4.19 |
| 11:57 ET | 100 | 4.185 |
| 12:08 ET | 10486 | 4.1499 |
| 12:10 ET | 1794 | 4.15 |
| 12:14 ET | 3000 | 4.15 |
| 12:15 ET | 1230 | 4.16 |
| 12:21 ET | 6800 | 4.165 |
| 12:24 ET | 500 | 4.1601 |
| 12:28 ET | 500 | 4.165 |
| 12:30 ET | 100 | 4.17 |
| 12:33 ET | 225 | 4.16 |
| 12:35 ET | 600 | 4.165 |
| 12:37 ET | 100 | 4.165 |
| 12:39 ET | 220 | 4.17 |
| 12:42 ET | 147 | 4.161 |
| 12:44 ET | 2175 | 4.155 |
| 12:48 ET | 1721 | 4.155 |
| 12:51 ET | 1300 | 4.165 |
| 12:55 ET | 100 | 4.165 |
| 12:57 ET | 100 | 4.165 |
| 01:00 ET | 1900 | 4.17 |
| 01:04 ET | 100 | 4.165 |
| 01:06 ET | 1880 | 4.16 |
| 01:08 ET | 100 | 4.165 |
| 01:09 ET | 100 | 4.165 |
| 01:13 ET | 2321 | 4.18 |
| 01:15 ET | 3016 | 4.19 |
| 01:18 ET | 500 | 4.185 |
| 01:20 ET | 300 | 4.18 |
| 01:24 ET | 1000 | 4.175 |
| 01:26 ET | 1985 | 4.165 |
| 01:27 ET | 3400 | 4.185 |
| 01:29 ET | 7755 | 4.2025 |
| 01:31 ET | 1025 | 4.2031 |
| 01:33 ET | 2900 | 4.225 |
| 01:36 ET | 2383 | 4.24 |
| 01:38 ET | 870 | 4.25 |
| 01:40 ET | 100 | 4.2411 |
| 01:42 ET | 8073 | 4.235 |
| 01:44 ET | 1300 | 4.2307 |
| 01:45 ET | 2564 | 4.225 |
| 01:47 ET | 1292 | 4.225 |
| 01:49 ET | 1032 | 4.235 |
| 01:51 ET | 500 | 4.233 |
| 01:54 ET | 247 | 4.235 |
| 01:58 ET | 500 | 4.225 |
| 02:00 ET | 600 | 4.225 |
| 02:02 ET | 1800 | 4.195 |
| 02:03 ET | 200 | 4.195 |
| 02:07 ET | 1831 | 4.215 |
| 02:12 ET | 1000 | 4.2185 |
| 02:14 ET | 1350 | 4.215 |
| 02:18 ET | 300 | 4.21 |
| 02:21 ET | 200 | 4.22 |
| 02:23 ET | 400 | 4.215 |
| 02:25 ET | 100 | 4.215 |
| 02:27 ET | 100 | 4.215 |
| 02:32 ET | 100 | 4.215 |
| 02:34 ET | 901 | 4.22 |
| 02:43 ET | 100 | 4.225 |
| 02:45 ET | 100 | 4.225 |
| 02:48 ET | 165 | 4.225 |
| 02:50 ET | 600 | 4.235 |
| 02:52 ET | 150 | 4.239 |
| 02:57 ET | 100 | 4.235 |
| 03:01 ET | 300 | 4.23 |
| 03:03 ET | 500 | 4.215 |
| 03:06 ET | 500 | 4.2157 |
| 03:08 ET | 400 | 4.225 |
| 03:14 ET | 3499 | 4.23 |
| 03:15 ET | 300 | 4.225 |
| 03:19 ET | 305 | 4.225 |
| 03:24 ET | 2420 | 4.24 |
| 03:26 ET | 544 | 4.25 |
| 03:28 ET | 1860 | 4.245 |
| 03:30 ET | 400 | 4.25 |
| 03:32 ET | 873 | 4.25 |
| 03:33 ET | 200 | 4.245 |
| 03:35 ET | 8340 | 4.245 |
| 03:37 ET | 4800 | 4.25 |
| 03:39 ET | 705 | 4.26 |
| 03:42 ET | 100 | 4.255 |
| 03:44 ET | 200 | 4.26 |
| 03:46 ET | 400 | 4.255 |
| 03:48 ET | 1800 | 4.245 |
| 03:50 ET | 5542 | 4.24 |
| 03:51 ET | 1298 | 4.255 |
| 03:53 ET | 9501 | 4.265 |
| 03:55 ET | 6562 | 4.28 |
| 03:57 ET | 3521 | 4.275 |
| 04:00 ET | 19968 | 4.26 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 655.4M | -16.1x | --- |
AnaptysBio Inc | 648.4M | -3.5x | --- |
Korro Bio Inc | 654.6M | -2.3x | --- |
Alumis Inc | 653.9M | -3.3x | --- |
Savara Inc | 653.5M | -9.2x | --- |
Tectonic Therapeutic Inc | 647.7M | -2.4x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). In addition to the rare disease programs, it has two oncology product candidates in clinical development. Etigilimab is an IgG1 monoclonal antibody which binds to the human T-cell immunoreceptor with Ig and ITIM domains (TIGIT) receptor on immune cells to improve the activation and effectiveness of T-cell and NK cell antitumor activity. Navicixizumab is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Navicixizumab is developed for the treatment of late line ovarian cancer.
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $655.4M |
|---|---|
Revenue (TTM) | $1.2M |
Shares Outstanding | 153.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.99 |
EPS | $-0.26 |
Book Value | $0.36 |
P/E Ratio | -16.1x |
Price/Sales (TTM) | 540.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,918.95% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
